Company Suspends Financial Guidance While Evaluating Strategic Options
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 12 2026
0mins
In connection with the company's previously announced engagement of Guggenheim Securities to evaluate strategic and financing options, the company is not providing financial guidance. The company, however, expects performance to be consistent with the financial indications it provided on the 2025 fourth quarter and full year earnings call. The company does not intend to provide forward-looking financial guidance while the strategic process is ongoing.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SNBR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SNBR
Wall Street analysts forecast SNBR stock price to rise
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 1.630
Low
5.00
Averages
5.50
High
6.00
Current: 1.630
Low
5.00
Averages
5.50
High
6.00
About SNBR
Sleep Number Corporation is a wellness technology company. The Company is engaged in designing, manufacturing, marketing, and distribution of sleep solutions. Its wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through its Climate360 smart bed or applying its 24 billion hours of longitudinal sleep data and expertise to research with global institutions. The Company’s smart beds provide unmatched features, benefits and comfort that can lead to improved sleep health and wellness for both sleepers. Its active temperature balancing technology supports the ideal climate for both sleepers and solves a prevalent sleep challenge. The Company’s smart bed ecosystem includes a full line of FlexFit smart adjustable bases that seamlessly integrate with Sleep Number smart beds for an individualized sleep experience that is proven to deliver more restful sleep per night.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sleep Number Under Investigation Amid Poor Q1 Results
- Declining Financial Performance: Sleep Number reported Q1 2026 results with a GAAP EPS of -$2.19, missing consensus estimates by $1.72, and revenue of $318.99 million, reflecting an 18.9% year-over-year decline, indicating severe profitability challenges for the company.
- Suspension of Financial Guidance: The company suspended its financial guidance, citing the engagement of Guggenheim Securities to evaluate strategic and financing options, which suggests a proactive approach to address its current financial difficulties.
- Significant Stock Price Drop: Following the earnings report, Sleep Number's stock price fell by $0.55, or 22.45%, closing at $1.90 per share, reflecting investor concerns regarding the company's future outlook and financial health.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Sleep Number and its executives engaged in securities fraud or other unlawful business practices, potentially leading to a class action lawsuit, which could further exacerbate market concerns about its governance structure.
See More
Sleep Number Q1 2026 Earnings Call Insights
- Liquidity Improvement: Sleep Number reached an agreement with existing lenders that adds $55 million in liquidity, including a new $25 million term loan, allowing time to focus on a long-term capital structure solution, thereby alleviating short-term financial pressures.
- Sales Performance Recovery: The company reported net sales of $319 million in Q1, which, while 19% lower year-over-year, aligns with analysts' expectations of $321 million, demonstrating resilience in the market recovery despite macroeconomic uncertainties.
- Product Line Success: The newly launched ComfortNext Lux mattress has become the top-selling product at approximately $4,000, and during the launch period, stores featuring the new lineup saw a 12% higher average revenue per unit (ARU) compared to previous products, indicating positive consumer reception.
- Effective Cost Control: Since the beginning of 2025, the company has identified over $235 million in annualized savings, with $200 million already executed, showcasing effective cost management that supports future profitability enhancements.
See More
Sleep Number Q1 Earnings Miss Expectations with Significant Losses
- Severe Earnings Loss: Sleep Number reported a Q1 GAAP EPS of -$2.19, missing expectations by $1.72, indicating significant challenges in profitability for the company.
- Revenue Decline: The company generated $318.99 million in revenue for Q1, an 18.9% year-over-year decrease, failing to meet expectations and reflecting pressures from weak market demand and declining sales.
- Adjusted EBITDA Drop: Adjusted EBITDA fell to $6 million, down 74%, primarily driven by a decline in net sales and associated loss of fixed cost leverage, although partially offset by lower operating expenses.
- Deteriorating Cash Flow: Year-to-date, net cash used in operating activities was $8 million, down $5 million from last year, with free cash flow showing a use of $13.2 million, highlighting difficulties in cash flow management.
See More
Sleep Number Secures $55M Liquidity Boost Amid Turnaround Efforts
- Liquidity Agreement: Sleep Number has reached an agreement with lenders to secure $55 million in liquidity, including a $25 million term loan, which provides essential funding to support its turnaround strategy and maintain competitiveness in the market.
- Covenant Relief: The agreement also eases certain financial and liquidity covenants, allowing the company greater flexibility to execute its product and marketing plans, particularly as it approaches the Memorial Day selling season, which is expected to drive sales growth.
- Stock Surge: Sleep Number's shares soared over 34% in premarket trading to $2.97; however, the stock remains more than 75% below its 52-week high, indicating market caution regarding its long-term recovery potential.
- Strategic Restructuring: The CFO highlighted that Sleep Number will continue to prioritize resetting its capital structure while planning to roll out a new product portfolio and marketing campaign to maximize value and attract more consumers.
See More
Sleep Number Launches New Personalized Comfort Marketing Campaign
- New Marketing Campaign: Sleep Number has launched a new integrated marketing campaign titled 'To a Good Life's Sleep,' which emphasizes personalized adjustable comfort, marking a significant phase in the company's brand evolution.
- Strategic Shift: This campaign not only focuses on product features but also highlights user comfort experiences, reflecting the company's shift from feature-centric to benefit-driven marketing strategies, which is expected to enhance its competitiveness in the premium market.
- Brand Awareness Growth: According to the brand tracker completed in January 2026, brand consideration among premium shoppers increased by 10%, indicating the effectiveness of the new marketing strategy, particularly in key drivers such as value, quality, and individualized comfort.
- Product Line Support: The new campaign supports Sleep Number's entire product range, from entry-level options to premium smart beds, ensuring a clear benefit-led narrative across all price points, further solidifying its market leadership.
See More
Mattress Brand Faces Harsh Reckoning Amid Debt Crisis
- Debt Crisis Intensifies: The mattress brand is facing severe challenges due to debt-fueled buyback strategies, with shrinking cash flow leading to deteriorating financial conditions that could impact future operational capabilities.
- Shareholder Risks Rise: As the credit deadline looms, the risks faced by common shareholders significantly increase, potentially leading to a substantial decrease in shareholder value and affecting investor confidence.
- Capital Allocation Missteps: The company's gamble on capital allocation has failed to yield the expected returns, exacerbating financial pressures and forcing management to reassess its strategic direction.
- Negative Market Reaction: The market holds a pessimistic view of the brand's future prospects, which could lead to further declines in stock price, impacting the company's financing capabilities and market competitiveness.
See More
Sleep Number Under Investigation Amid Poor Q1 Results
- Declining Financial Performance: Sleep Number reported Q1 2026 results with a GAAP EPS of -$2.19, missing consensus estimates by $1.72, and revenue of $318.99 million, reflecting an 18.9% year-over-year decline, indicating severe profitability challenges for the company.
- Suspension of Financial Guidance: The company suspended its financial guidance, citing the engagement of Guggenheim Securities to evaluate strategic and financing options, which suggests a proactive approach to address its current financial difficulties.
- Significant Stock Price Drop: Following the earnings report, Sleep Number's stock price fell by $0.55, or 22.45%, closing at $1.90 per share, reflecting investor concerns regarding the company's future outlook and financial health.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Sleep Number and its executives engaged in securities fraud or other unlawful business practices, potentially leading to a class action lawsuit, which could further exacerbate market concerns about its governance structure.
See More
Sleep Number Q1 2026 Earnings Call Insights
- Liquidity Improvement: Sleep Number reached an agreement with existing lenders that adds $55 million in liquidity, including a new $25 million term loan, allowing time to focus on a long-term capital structure solution, thereby alleviating short-term financial pressures.
- Sales Performance Recovery: The company reported net sales of $319 million in Q1, which, while 19% lower year-over-year, aligns with analysts' expectations of $321 million, demonstrating resilience in the market recovery despite macroeconomic uncertainties.
- Product Line Success: The newly launched ComfortNext Lux mattress has become the top-selling product at approximately $4,000, and during the launch period, stores featuring the new lineup saw a 12% higher average revenue per unit (ARU) compared to previous products, indicating positive consumer reception.
- Effective Cost Control: Since the beginning of 2025, the company has identified over $235 million in annualized savings, with $200 million already executed, showcasing effective cost management that supports future profitability enhancements.
See More
Sleep Number Q1 Earnings Miss Expectations with Significant Losses
- Severe Earnings Loss: Sleep Number reported a Q1 GAAP EPS of -$2.19, missing expectations by $1.72, indicating significant challenges in profitability for the company.
- Revenue Decline: The company generated $318.99 million in revenue for Q1, an 18.9% year-over-year decrease, failing to meet expectations and reflecting pressures from weak market demand and declining sales.
- Adjusted EBITDA Drop: Adjusted EBITDA fell to $6 million, down 74%, primarily driven by a decline in net sales and associated loss of fixed cost leverage, although partially offset by lower operating expenses.
- Deteriorating Cash Flow: Year-to-date, net cash used in operating activities was $8 million, down $5 million from last year, with free cash flow showing a use of $13.2 million, highlighting difficulties in cash flow management.
See More
Sleep Number Secures $55M Liquidity Boost Amid Turnaround Efforts
- Liquidity Agreement: Sleep Number has reached an agreement with lenders to secure $55 million in liquidity, including a $25 million term loan, which provides essential funding to support its turnaround strategy and maintain competitiveness in the market.
- Covenant Relief: The agreement also eases certain financial and liquidity covenants, allowing the company greater flexibility to execute its product and marketing plans, particularly as it approaches the Memorial Day selling season, which is expected to drive sales growth.
- Stock Surge: Sleep Number's shares soared over 34% in premarket trading to $2.97; however, the stock remains more than 75% below its 52-week high, indicating market caution regarding its long-term recovery potential.
- Strategic Restructuring: The CFO highlighted that Sleep Number will continue to prioritize resetting its capital structure while planning to roll out a new product portfolio and marketing campaign to maximize value and attract more consumers.
See More
Sleep Number Launches New Personalized Comfort Marketing Campaign
- New Marketing Campaign: Sleep Number has launched a new integrated marketing campaign titled 'To a Good Life's Sleep,' which emphasizes personalized adjustable comfort, marking a significant phase in the company's brand evolution.
- Strategic Shift: This campaign not only focuses on product features but also highlights user comfort experiences, reflecting the company's shift from feature-centric to benefit-driven marketing strategies, which is expected to enhance its competitiveness in the premium market.
- Brand Awareness Growth: According to the brand tracker completed in January 2026, brand consideration among premium shoppers increased by 10%, indicating the effectiveness of the new marketing strategy, particularly in key drivers such as value, quality, and individualized comfort.
- Product Line Support: The new campaign supports Sleep Number's entire product range, from entry-level options to premium smart beds, ensuring a clear benefit-led narrative across all price points, further solidifying its market leadership.
See More
Mattress Brand Faces Harsh Reckoning Amid Debt Crisis
- Debt Crisis Intensifies: The mattress brand is facing severe challenges due to debt-fueled buyback strategies, with shrinking cash flow leading to deteriorating financial conditions that could impact future operational capabilities.
- Shareholder Risks Rise: As the credit deadline looms, the risks faced by common shareholders significantly increase, potentially leading to a substantial decrease in shareholder value and affecting investor confidence.
- Capital Allocation Missteps: The company's gamble on capital allocation has failed to yield the expected returns, exacerbating financial pressures and forcing management to reassess its strategic direction.
- Negative Market Reaction: The market holds a pessimistic view of the brand's future prospects, which could lead to further declines in stock price, impacting the company's financing capabilities and market competitiveness.
See More
